Most sold healthcare stocks in Q3 2018
See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2018, measured as net reductions in reported share positions from Q2 2018 into Q3 2018. Notable reductions at the top of this list include ELI LILLY & CO (LLY), GILEAD SCIENCES INC (GILD), UNITEDHEALTH GROUP INC (UNH), BRISTOL-MYERS SQUIBB CO (BMY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | -9,812,103 | -$262.77M | 0 | 0 | 5 | 1 | 5 |
| GILD | GILEAD SCIENCES INC | -9,079,679 | -$438.02M | 0 | 5 | 3 | 1 | 9 |
| UNH | UNITEDHEALTH GROUP INC | -5,041,180 | -$787.73M | 0 | 2 | 11 | 2 | 15 |
| BMY | BRISTOL-MYERS SQUIBB CO | -5,026,374 | -$81.58M | 0 | 2 | 4 | 0 | 10 |
| SNY | SANOFI-ADR | -4,017,032 | $126.31M | 0 | 0 | 2 | 2 | 3 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -2,638,300 | $135.72M | 0 | 0 | 2 | 0 | 2 |
| HCA | HCA HEALTHCARE INC | -2,620,658 | -$165.96M | 1 | 1 | 2 | 0 | 4 |
| AMRN | AMARIN CORP PLC -ADR | -2,602,135 | -$7.83M | 0 | 0 | 0 | 1 | 0 |
| A | AGILENT TECHNOLOGIES INC | -1,726,701 | -$77.23M | 0 | 0 | 2 | 1 | 3 |
| CPRX | CATALYST PHARMACEUTICALS INC | -1,236,778 | -$2.74M | 0 | 0 | 1 | 0 | 1 |
| JNJ | JOHNSON & JOHNSON | -1,218,603 | $166.06M | 0 | 4 | 10 | 1 | 17 |
| PRGO | Perrigo Company PLC | -1,208,827 | -$95.25M | 1 | 1 | 2 | 0 | 4 |
| BAX | BAXTER INTERNATIONAL INC | -1,135,632 | $45.79M | 0 | 0 | 1 | 1 | 5 |
| VREX | VAREX IMAGING CORP | -1,089,740 | -$41.49M | 0 | 0 | 1 | 1 | 1 |
| EW | EDWARDS LIFESCIENCES CORP | -1,084,583 | -$58.14M | 1 | 1 | 3 | 1 | 5 |
| TMO | THERMO FISHER SCIENTIFIC INC | -1,047,015 | $75.03M | 1 | 0 | 9 | 1 | 14 |
| ELV | ELEVANCE HEALTH INC | -1,032,302 | $74.39M | 0 | 1 | 4 | 1 | 7 |
| GRFS | GRIFOLS SA-ADR | -945,081 | -$21.50M | 0 | 0 | 2 | 0 | 2 |
| CTLT | CATALENT INC | -875,143 | -$28.75M | 0 | 0 | 3 | 0 | 3 |
| VKTX | VIKING THERAPEUTICS INC | -832,500 | -$3.64M | 0 | 0 | 0 | 1 | 0 |
| SRNE | SORRENTO THERAPEUTICS INC | -801,247 | -$4.37M | 0 | 0 | 1 | 0 | 2 |
| ISRG | INTUITIVE SURGICAL INC | -798,276 | -$182.26M | 0 | 2 | 1 | 1 | 4 |
| PODD | INSULET CORP | -756,600 | -$60.94M | 0 | 0 | 1 | 0 | 1 |
| BDX | BECTON DICKINSON AND CO | -623,527 | $9.59M | 0 | 1 | 7 | 1 | 9 |
| VCEL | VERICEL CORP | -614,300 | -$5.83M | 0 | 0 | 1 | 0 | 1 |
| ABBV | ABBVIE INC | -585,696 | -$54.42M | 0 | 4 | 3 | 0 | 11 |
| CNC | CENTENE CORP | -560,994 | -$24.99M | 0 | 1 | 4 | 0 | 5 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | -550,600 | -$2.00M | 0 | 0 | 1 | 0 | 1 |
| BRKR | BRUKER CORP | -528,100 | -$15.48M | 0 | 0 | 1 | 0 | 1 |
| ITCI | INTRA-CELLULAR THERAPIES INC | -498,600 | -$9.27M | 0 | 0 | 1 | 0 | 2 |
| DVA | DAVITA INC | -454,900 | $58.38M | 0 | 0 | 1 | 0 | 3 |
| ALGN | ALIGN TECHNOLOGY INC | -428,385 | $409.37M | 0 | 1 | 4 | 0 | 6 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | -425,778 | -$16.24M | 0 | 0 | 0 | 1 | 1 |
| HCSG | HEALTHCARE SERVICES GROUP | -422,639 | -$18.49M | 1 | 2 | 0 | 1 | 3 |
| IQV | IQVIA HOLDINGS INC | -400,783 | $261.29M | 1 | 0 | 2 | 0 | 3 |
| CORT | CORCEPT THERAPEUTICS INC | -382,900 | -$17.03M | 0 | 0 | 1 | 0 | 1 |
| OPK | OPKO HEALTH INC | -341,358 | -$1.07M | 0 | 0 | 1 | 0 | 1 |
| IDXX | IDEXX LABORATORIES INC | -313,483 | $184.18M | 0 | 1 | 3 | 0 | 5 |
| INCY | INCYTE CORP | -300,881 | -$33.81M | 0 | 1 | 1 | 0 | 2 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | -293,111 | $38.08M | 0 | 1 | 5 | 0 | 8 |
| SAGE | SAGE THERAPEUTICS INC | -289,200 | -$46.64M | 0 | 0 | 1 | 0 | 1 |
| MTD | METTLER-TOLEDO INTERNATIONAL | -284,253 | -$163.41M | 0 | 1 | 0 | 1 | 1 |
| AXGN | AXOGEN INC | -276,600 | -$9.88M | 0 | 0 | 1 | 0 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | -272,200 | -$648.00K | 0 | 0 | 1 | 0 | 1 |
| BIO | BIO-RAD LABORATORIES-A | -270,815 | -$57.47M | 0 | 1 | 1 | 0 | 2 |
| WST | WEST PHARMACEUTICAL SERVICES | -267,056 | -$17.38M | 0 | 0 | 2 | 0 | 2 |
| CUTR | CUTERA INC | -266,200 | -$27.77M | 0 | 0 | 1 | 0 | 1 |
| HALO | HALOZYME THERAPEUTICS INC | -247,950 | -$2.74M | 0 | 2 | 1 | 0 | 4 |
| MGNX | MACROGENICS INC | -240,300 | -$6.64M | 0 | 0 | 1 | 0 | 1 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | -228,919 | -$4.54M | 0 | 0 | 0 | 1 | 0 |
Frequently asked questions about Most sold healthcare stocks in Q3 2018
What are the most sold Healthcare stocks in Q3 2018?
The most sold healthcare stocks in Q3 2018 are those with the largest decrease in reported share counts across institutional investors compared to Q2 2018, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2018?
Among filers in this sector, net reductions were largest in companies such as ELI LILLY & CO (LLY), GILEAD SCIENCES INC (GILD), UNITEDHEALTH GROUP INC (UNH), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2018).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.